Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Access
All
Content accessible to Me
Refine by Date
From
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
—
To
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://jnccn.org/search?f_0=author&q_0=Catherine+Larkin
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
Search Results
You are looking at
1
-
1
of
1
items for
Author: Catherine Larkin
x
Refine by Access: All
x
Clear All
Modify Search
Items per page
10
20
50
Sort by
Relevance
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Full access
Is the Battle Over Bevacizumab Coverage Looming?
Catherine Larkin
In
Journal of the National Comprehensive Cancer Network Volume 9 (2011): Issue 3 (Mar 2011)
Mar 2011
Items per page
10
20
50
Sort by
Relevance
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
[34.231.180.210]
34.231.180.210
